{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:17:49Z","timestamp":1770499069557,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1023\/a:1018882804607","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T16:23:59Z","timestamp":1045671839000},"page":"2111-2115","source":"Crossref","is-referenced-by-count":96,"title":["Metronidazole Resistance Reduces Efficacy of Triple Therapy and Leads to Secondary Clarithromycin Resistance"],"prefix":"10.1007","volume":"42","author":[{"given":"Martin J. M.","family":"Buckley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Xiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor T.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colm A.","family":"O'Morain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"294002_CR1","first-page":"109","volume":"2","author":"JG Coghlan","year":"1987","unstructured":"Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C: Campylobacter pylori and recurrence of duodenal ulcers\u2014a 12 month follow-up study. Lancet 2:109-111, 1987","journal-title":"Lancet"},{"key":"294002_CR2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","volume":"2","author":"BJ Marshall","year":"1988","unstructured":"Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M2, Waters TE, Sanderson CR: A prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2:1437-1442, 1988","journal-title":"Lancet"},{"key":"294002_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gut.35.1.15","volume":"35","author":"RPH Logan","year":"1994","unstructured":"Logan RPH, Gummett PA, Misiewicz JJ, Karim QM, Walker MM, Baron JH: One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut 35:15-18, 1994","journal-title":"Gut"},{"key":"294002_CR4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(94)91460-5","volume":"343","author":"SW Hosking","year":"1994","unstructured":"Hosking SW, Ling TKW, Chung SCS, et al: Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment. Lancet 343:508-510, 1994","journal-title":"Lancet"},{"key":"294002_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2036.1994.tb00304.x","volume":"8","author":"JG Penston","year":"1994","unstructured":"Penston JG: Review article: Helicobacter pylori eradication\u2014understandable caution but no excuse for inertia. Aliment Pharmacol Ther 8:369-389, 1994","journal-title":"Aliment Pharmacol Ther"},{"key":"294002_CR6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/gut.31.9.999","volume":"31","author":"T O'Riordan","year":"1990","unstructured":"O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, O'Morain C: Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31:999-1002, 1990","journal-title":"Gut"},{"key":"294002_CR7","first-page":"493","volume":"102","author":"HJ O'Connor","year":"1992","unstructured":"O'Connor HJ: Eradication of Helicobacter pylori: Therapies and clinical implications. Postgrad Med J 102:493-496, 1992","journal-title":"Postgrad Med J"},{"key":"294002_CR8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0016-5085(92)90095-G","volume":"102","author":"DY Graham","year":"1992","unstructured":"Graham DY, Lew GM, Malaty HM, Evans DG, Evans DG Jr, Klein PD, Alpert LC, Genta RM: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102:493-496, 1992","journal-title":"Gastroenterology"},{"key":"294002_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/00365549409011802","volume":"26","author":"LA Noach","year":"1994","unstructured":"Noach LA, Lagenberg WL, Bertola MA, Dankert J, Tytgat GNJ: Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 26:321-327, 1994","journal-title":"Scand J Infect Dis"},{"key":"294002_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.1992.tb00556.x","volume":"6","author":"GD Bell","year":"1992","unstructured":"Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, Harrison G, Trowell JE: Experience with \u201ctriple\u201d anti-Helicobacter pylori eradication therapy: Side-effects and importance of testing pre-treatment bacterial isolates for metronidazole resistance. Aliment Pharmacol Ther 6:427-435, 1992","journal-title":"Aliment Pharmacol Ther"},{"key":"294002_CR11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-199407000-00004","volume":"6","author":"LA Noach","year":"1994","unstructured":"Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ: Treatment of Helicobacter pylori infection: An evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 6:585-591, 1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR12","first-page":"A947","volume":"102","author":"HX Xia","year":"1992","unstructured":"Xia HX, Daw MA, Beattie S, Keane CT, O'Morain CA: The influence of metronidazole resistance on triple therapy for Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 102:A947, 1992 (abstract)","journal-title":"Am J Gastroenterol"},{"key":"294002_CR13","first-page":"1545","volume":"85","author":"Y Glupcznski","year":"1990","unstructured":"Glupcznski Y, Burette A: Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am J Gastroenterol 85:1545-1551, 1990","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"294002_CR14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/0140-6736(91)93181-8","volume":"337","author":"F Megraud","year":"1991","unstructured":"Megraud F, Boyanova L, Lamouliatte H: Activity of lansoprazole against H. pylori. Lancet 337(1):1486, 1991 (letter)","journal-title":"Lancet"},{"issue":"suppl167","key":"294002_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00365528909091311","volume":"24","author":"P Unge","year":"1989","unstructured":"Unge P, Gad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis. Scand J Gastroenterol 24(suppl 167):49-54, 1989","journal-title":"Scand J Gastroenterol"},{"key":"294002_CR16","first-page":"481","volume":"4","author":"JA Louw","year":"1992","unstructured":"Louw JA, Zak J, Jaskiewicz K, Lucke W, LeRoux E, Winter T, Lastouica A, Marks IN: Omeprazole may clear but does not eradicate H. pylori. Eur J Gastroenterol Hepatol 4:481-485, 1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR17","first-page":"727","volume":"22","author":"CAM McNulty","year":"1988","unstructured":"McNulty CAM, Dent JC, Ford GA, Wilkinson SP: Inhibitory antimicrobial concentrations against H. pylori in gastric mucosa. J Antimicrob Chemother 22:727-738, 1988","journal-title":"J Antimicrob Chemother"},{"key":"294002_CR18","first-page":"1860","volume":"88","author":"WL Peterson","year":"1993","unstructured":"Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, Stratton CW, Drnec J, Prokocimer P, Siepman N: Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomised double-blind trial. Am J Gastroenterol 88:1860-1864, 1993","journal-title":"Am J Gastroenterol"},{"key":"294002_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/22.5.631","volume":"22","author":"DJ Hardy","year":"1988","unstructured":"Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB: Susceptibility of Campylobacter pylori to macrolides and flouroquinolones. J Antimicrobial Chemother 22:631-636, 1988","journal-title":"J Antimicrobial Chemother"},{"key":"294002_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","volume":"6","author":"F Bazzoli","year":"1994","unstructured":"Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al: Short-term, low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 6:773-777, 1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","volume":"1","author":"T Lind","year":"1996","unstructured":"Lind T, Veldhuyzen van Zanten SJO, Unge P, Spiller RC, Bayerdorffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C, Idstrom J-P: Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study. Helicobacter 1:138-144, 1996","journal-title":"Helicobacter"},{"key":"294002_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00042737-199303000-00004","volume":"5","author":"HX Xia","year":"1993","unstructured":"Xia HX, Daw MA, Sant S, Beattie S, Keane CT, O'Morain CA: Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 5:141-144, 1993","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02942098","volume":"162","author":"HX Xia","year":"1993","unstructured":"Xia HX, Daw MA, Keane CT, O'Morain CA: The prevalence of metronidazole-resistant Helicobacter pylori in Irish dyspeptic patients. Ir J Med Sci 162:91-94, 1993","journal-title":"Ir J Med Sci"},{"key":"294002_CR24","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/AAC.38.10.2357","volume":"38","author":"HX Xia","year":"1994","unstructured":"Xia HX, Keane CT, Beattie S, O'Morain CA. Standardisation of disc diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 38:2357-2361, 1994","journal-title":"Antimicrob Agents Chemother"},{"key":"294002_CR25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/37.3.473","volume":"37","author":"HX Xia","year":"1996","unstructured":"Xia HX, Buckley M, Keane CT, O'Morain CA: Clarithromycin resistance in Helicobacter pylori: Prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother 37:473-481, 1996","journal-title":"J Antimicrob Chemother"},{"issue":"suppl220","key":"294002_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365529609094747","volume":"31","author":"P Unge","year":"1996","unstructured":"Unge P, Berstad A: Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol 31(suppl 220):27-40, 1996","journal-title":"Scand J Gastroenterol"},{"key":"294002_CR27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF01960875","volume":"11","author":"European Study Group on Antibiotic Susceptibility of Helicobacter pylori","year":"1992","unstructured":"European Study Group on Antibiotic Susceptibility of Helicobacter pylori: Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 11:777-781, 1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"294002_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0140-6736(90)90772-W","volume":"335","author":"MCJM Becx","year":"1990","unstructured":"Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW: Metronidazole-resistant Helicobacter pylori. Lancet 335:539-540, 1990","journal-title":"Lancet"},{"key":"294002_CR29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0140-6736(90)91043-A","volume":"335","author":"Y Glupczynski","year":"1990","unstructured":"Glupczynski Y, Burette A, de Koster E, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, de Vos D: Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977, 1990","journal-title":"Lancet"},{"key":"294002_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.36.1.163","volume":"36","author":"H Rautelin","year":"1992","unstructured":"Rautelin H, Seppala K, Renkonen O-V, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy of Helicobacter pylori. infections. Antimicrob Agents Chemother 36:163-166, 1992","journal-title":"Antimicrob Agents Chemother"},{"key":"294002_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00042737-199303000-00013","volume":"5","author":"AA van Zwet","year":"1993","unstructured":"van Zwet AA, Thijs JC, Oom JAJ, Hoogeveen J, Duringshoff BL. Failure to eradicate Helicobacter in patients with metronidazole-resistant strains. Eur J Gastroenterol Hepatol 5:185-186, 1993","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/AAC.38.2.360","volume":"38","author":"AA van Zwet","year":"1994","unstructured":"van Zwet AA, Thijs, de Vries WS, Schiphius J, Snijder JAM: In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 38:360-362, 1994","journal-title":"Antimicrob Agents Chemother"},{"key":"294002_CR33","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/gut.35.11.1562","volume":"35","author":"N Banatvala","year":"1994","unstructured":"Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, Feldman RA: High prevalence of Helicobacter pylori. metronidazole resistance in migrants to east London: Relation with previous nitroimodazole exposure and gastroduodenal disease. Gut 35:1562-1566, 1994","journal-title":"Gut"},{"key":"294002_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","volume":"39","author":"B Weisblum","year":"1995","unstructured":"Weisblum B: Erythromycin resistance by ribosomal modification. Antimicrob Agents and Chemother 39:577-585, 1995","journal-title":"Antimicrob Agents and Chemother"},{"issue":"suppl1","key":"294002_CR35","first-page":"A67","volume":"37","author":"J Versalovic","year":"1995","unstructured":"Versalovic J, Kibler K, Small S, Graham DY, Go MF: Mutations in the 23S ribosomal RNA confer clarithromycin resistance in Helicobacter pylori. Gut 37(suppl 1):A67, 1995","journal-title":"Gut"},{"issue":"suppl2","key":"294002_CR36","first-page":"A8","volume":"39","author":"K Hult\u00e9n","year":"1996","unstructured":"Hult\u00e9n K, Engstrand L: Acquired and persistent macrolide resistance in patients treated with clarithromycin. Gut 39(suppl 2):A8, 1996","journal-title":"Gut"},{"key":"294002_CR37","first-page":"835","volume":"7","author":"P Moayyedi","year":"1995","unstructured":"Moayyedi P, Sahay P, Tompkins DS, Axon ATR: Efficacy and optimum dose of omeprazole in a new one-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 7:835-840, 1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"294002_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.1995.tb00374.x","volume":"9","author":"MM Yousfi","year":"1995","unstructured":"Yousfi MM, El-Zimaity HMT, Al-Assi MT, Cole RA, Genta RM, Graham DY: Metronidazole, omeprazole and clarithromycin: An effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 9:209-212, 1995","journal-title":"Aliment Pharmacol Ther"},{"key":"294002_CR39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","volume":"345","author":"W de Boer","year":"1995","unstructured":"de Boer W, Driessen W, Jansz A, Tytgat G: Effect of acid suppression on efficacy of treatment for Helicobacter pylori. Lancet 345:817-820, 1995","journal-title":"Lancet"},{"key":"294002_CR40","first-page":"1366","volume":"89","author":"R Cayla","year":"1994","unstructured":"Cayla R, Zerbib F, de Mascare F, Megraud F, Lamouliatte H: Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for H. pylori eradication. Am J Gastroenterol 89:1366, 1994 (abstract)","journal-title":"Am J Gastroenterol"},{"key":"294002_CR41","first-page":"A240","volume":"108","author":"TCK Tham","year":"1995","unstructured":"Tham TCK, Collins JSA, McCormick C, Sloan JM, Bamford K, Watson RGP: Randomised controlled trial of ranitidine and omeprazole and their combination with antibiotics in the eradication of Helicobacter pylori. Gastroenterology 108:A240, 1995 (abstract)","journal-title":"Gastroenterology"},{"key":"294002_CR42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.1995.tb00349.x","volume":"9","author":"GD Bell","year":"1995","unstructured":"Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, Jones PH, Brown C: Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 9:41-46, 1995","journal-title":"Aliment Pharmacol Ther"},{"key":"294002_CR43","doi-asserted-by":"crossref","first-page":"A143","DOI":"10.1016\/0016-5085(95)23237-0","volume":"108","author":"H Lamouliatte","year":"1995","unstructured":"Lamouliatte H, Cayla R, Zerbib F, Megraud F: Triple therapy with proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori eradication. Gastroenterology 108:A143, 1995 (abstract)","journal-title":"Gastroenterology"},{"key":"294002_CR44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(95)92957-6","volume":"345","author":"A Harris","year":"1995","unstructured":"Harris A, Misiewicz JJ: Hitting H. pylori for four. Lancet 345:806-807, 1995 (commentary)","journal-title":"Lancet"},{"key":"294002_CR45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2036.1997.87259000.x","volume":"11","author":"G Vautier","year":"1997","unstructured":"Vautier G, Scott BB: A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther 11:107-108, 1997","journal-title":"Aliment Pharmacol Ther"},{"key":"294002_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","volume":"9","author":"P Malfertheiner","year":"1997","unstructured":"Malfertheiner P, Megraud F, O'Morain C, Bell D, Porro GB, Deltenre M, Forman D, et al: Current European concepts in the management of H. pylori infection\u2014The Maastricht Consensus Report. Eur J Gastroenterol Hepatol 9:1-2, 1997","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018882804607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018882804607\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018882804607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T02:45:15Z","timestamp":1752461115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018882804607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["294002"],"URL":"https:\/\/doi.org\/10.1023\/a:1018882804607","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}